SCM
PBLS

Soleus Capital Management’s Parabilis Medicines Inc PBLS Stock Holding History

Soleus Capital Management’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1M Buy
+1,465,070
New +$40.5M 1.38% 19

Other funds holding PBLS

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Soleus Capital Management's PBLS Position: Q2 2026 in Review

Soleus Capital Management opened a new position in Parabilis Medicines Inc (PBLS) in Q2 2026: 1,465,070 shares worth $40.1M. The stake represents 1.38% of the portfolio and ranks #19 among its holdings.

37 funds tracked by Wall St. Rank hold PBLS as of Q2 2026.

  • Soleus Capital Management held 1,465,070 shares of Parabilis Medicines Inc worth $40.1M as of Q2 2026.
  • Parabilis Medicines Inc was a new Soleus Capital Management position in Q2 2026.
  • Parabilis Medicines Inc made up 1.38% of Soleus Capital Management's portfolio in Q2 2026, its #19 holding.
  • 37 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.